GlobalData's clinical trial report, "Nonmelanomatous Skin Cancer Global Clinical Trials Review, H1, 2012" provides data on the Nonmelanomatous Skin Cancer/Impaired Glucose Toleranceclinical trial scenario. This report provides elemental information and data relating to the clinical trials on Nonmelanomatous Skin Cancer/Impaired Glucose Tolerance. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Nonmelanomatous Skin Cancer/Impaired Glucose Tolerance. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
Understand the dynamics of a particular indication in a condensed manner
Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
Obtain discontinued trial listing for trials across the globe
Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Keywords:
Nonmelanomatous Skin Cancer/Impaired Glucose Tolerance Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Nonmelanomatous Skin Cancer/Impaired Glucose Tolerance, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.
Table of Contents
Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Nonmelanomatous Skin Cancer
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Countries Contributing to Clinical Trials in Asia-Pacific
Top Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Nonmelanomatous Skin Cancer
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Nonmelanomatous Skin Cancer Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Healthpoint Biotherapeutics
Clinical Trial Overview of Healthpoint Biotherapeutics
DUSA Pharmaceuticals, Inc
Clinical Trial Overview of DUSA Pharmaceuticals, Inc
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
Clinical Trial Overview of Top Universities / Institutes / Hospitals
Roswell Park Cancer Institute
Clinical Trial Overview of Roswell Park Cancer Institute
The University of Arizona
Clinical Trial Overview of The University of Arizona
Case Comprehensive Cancer Center
Clinical Trial Overview of Case Comprehensive Cancer Center
University of Alabama at Birmingham
Clinical Trial Overview of University of Alabama at Birmingham
University of Wisconsin Madison
Clinical Trial Overview of University of Wisconsin Madison
Children's Hospital & Research Center Oakland
Clinical Trial Overview of Children's Hospital & Research Center Oakland
Royal Adelaide Hospital
Clinical Trial Overview of Royal Adelaide Hospital
The Queen's Medical Center
Clinical Trial Overview of The Queen's Medical Center
Oregon Health and Science University
Clinical Trial Overview of Oregon Health and Science University
University Hospital Basel
Clinical Trial Overview of University Hospital Basel
Abramson Cancer Center
Clinical Trial Overview of Abramson Cancer Center
Mayo Clinic
Clinical Trial Overview of Mayo Clinic
Eastern Virginia Medical School
Clinical Trial Overview of Eastern Virginia Medical School
Yale University
Clinical Trial Overview of Yale University
Hoag Memorial Hospital Presbyterian
Clinical Trial Overview of Hoag Memorial Hospital Presbyterian
Baylor College of Medicine
Clinical Trial Overview of Baylor College of Medicine
The Medical University of Graz
Clinical Trial Overview of The Medical University of Graz
Northwestern University
Clinical Trial Overview of Northwestern University
University of Massachusetts
Clinical Trial Overview of University of Massachusetts
University of California, Irvine
Clinical Trial Overview of University of California, Irvine
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source
List of Tables
Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials by Zone, 2012*
Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2012*
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Europe, Top Countries, 2012*
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, North America, Top Countries, 2012*
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, G7 Countries, 2012*
Nonmelanomatous Skin Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials by Phase, 2012*
Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012*
Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
Nonmelanomatous Skin Cancer Therapeutics Market, Global, Withdrawn Clinical Trials, 2012*
Nonmelanomatous Skin Cancer Therapeutics Market, Global, Terminated Clinical Trials, 2012*
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Healthpoint Biotherapeutics, 2012*
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by DUSA Pharmaceuticals, Inc, 2012*
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012*
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2012*
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Arizona, 2012*
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2012*
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alabama at Birmingham, 2012*
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Wisconsin Madison, 2012*
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Hospital & Research Center Oakland, 2012*
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Royal Adelaide Hospital, 2012*
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The Queen's Medical Center, 2012*
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Oregon Health and Science University, 2012*
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Basel, 2012*
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Abramson Cancer Center, 2012*
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012*
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eastern Virginia Medical School, 2012*
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Yale University, 2012*
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Hoag Memorial Hospital Presbyterian, 2012*
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2012*
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The Medical University of Graz, 2012*
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2012*
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Massachusetts, 2012*
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Irvine, 2012*
List of Figures
Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials by Zone (%), 2012*
Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Europe, Top Countries (%), 2012*
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, G7 Countries (%), 2012*
Nonmelanomatous Skin Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials by Phase (%), 2012*
Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012*
Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
GlobalData Methodology
Nonmelanomatous Skin Cancer Global Clinical Trials Review, H1, 2012 published by GlobalData in June 30, 2012. This report consists of Pages: 75 and the price starts from US $ 2500.
